Sign in
4

Changes in Ownership

ANI PHARMACEUTICALS INC Filed Acc 0001871002-24-000006

SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $65.81 ($1,316,200)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Gassert Chad SVP - CORP. DEV. & STRATEGY 2024-03-11 Sale 10b5-1 −20,000 $65.81 $1,316,200 273,226 I
Open-market sales · 20,000 sh · avg $65.81 · $1,316,200
Loading xslF345X05/wk-form4_1710362669.xml…